Clinical Triggers to Initiate Intrapartum Penicillin Therapy for Prevention of Group B Streptococcus Infection

ABSTRACT

Despite national recommendations for prophylactic group B streptococci intrapartum penicillin therapy (GBS-IPT), there is little guidance for clinicians regarding to how to achieve the recommended 4 hours of therapy. We sought to identify clinical triggers for effective temporal prompts to initiate GBS-IPT to achieve the recommended duration of therapy. GBS-colonized women who delivered between 37 and 42 weeks were analyzed retrospectively. The clinical record was reviewed for clinical events including rupture of membranes, oxytocin therapy, 4-cm dilation, active labor, narcotic analgesia, epidural analgesia. In addition, combinations of these triggers were evaluated using the first appearance of 4-cm dilation or active labor, narcotic analgesia or epidural, and a composite indicator of each of these four triggers. Antibiotic duration and proportion receiving 4 hours of GBS-IPT for each trigger were compared with the conventional penicillin management the patient actually received (CM). Data were analyzed with z-test for proportions with Bonferroni correction and one-way analysis of variance. Two hundred thirteen women met study criteria and were reviewed. Using CM, 90.8% of nulliparas and 68.7% of parous women achieved adequate GBS-IPT. In nulliparas, each clinical trigger resulted in equivalent rates of adequate GBS-IPT compared with CM. The duration of therapy was less for 4-cm dilation, epidural, epidural or narcotic analgesia, and 4-cm dilation or active labor triggers in nulliparas, suggesting better identification of the period 4 hours prior to delivery. In parous women, clinical triggers did not perform better than CM. In nulliparous women, clinical triggers to initiate therapy may achieve high rates of GBS-IPT, with a significant decrease in the duration of antibiotic therapy. In nulliparous women, clinical triggers better identify the 4-hour window prior to delivery than CM.

Neonatal infection - group B streptococci (GBS) - antibiotics - labor

REFERENCES

• 1 Regan J A, Klebanoff M A, Nugent R P. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group.  Obstet Gynecol. 1991;  77 604-610
• 2 ACOG Committee Opinion . Number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns.  Obstet Gynecol. 2002;  100 1405-1412
• 3 ACOG Committee Opinion .Number 173. Prevention of early-onset group B streptococcal disease in newborns. Washington, DC; ACOG 1996
• 4 Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.  MMWR Recomm Rep. 1996;  45 1-24
• 5 Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.  Pediatrics. 1997;  99 489-496
• 6 Schrag S J, Zell E R, Lynfield R et al.. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.  N Engl J Med. 2002;  347 233-239
• 7 Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.  MMWR Recomm Rep. 2002;  51 1-22
• 8 de Cueto M, Sanchez M J, Sampedro A, Miranda J A, Herruzo A J, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus.  Obstet Gynecol. 1998;  91 112-114